Replies to post #180374 on Cytodyn Inc (CYDY)

[kgromax]

Something strange:

the Brazil regulator (Anvisa) lists Cytodyn as the sponsor.

While in the US, Cytodyn declared the Brazilian hospital (Albert Einstein) as the sponsor in the official clinicaltrial.gov database

We are used to the CEO shenanigans. Maybe he needs to declare Cytodyn for credibility in the Brazil, and declare Albert Einstein for crediblity in the US? But is this legal? Sponsorship entails specific legal and financial obligations

[SammieGo]

Q: Why does a company run a clinical trial (you know, clinical, like real patients) with its product?

A: To look at the efficacy of the drug (does it help, you know, clinically, in real patients?).


Q: How does a company find out if their drug is efficacious (you know, that it works, like helping patients get better)?

A: Run a clinical trial (you know, with real patients and stuff).

[misiu143]

--There will be a full clinical trial in Brazil , someone posted here recently it was approved .. so I will expect it should be very soon..And hopefully it will start and finish very fast , showing to the world what drug leronlimab is..

--People dying around the world , and not one good drug approved for immune stage of covid ..
How I understand that going recently with a family member threw this terrible situation.
We need leronlimab approval asap.

--Leronlimab is also -- HIV drug ,
When refusal to file was issue , it was not because of not clinically statistical results, it was because of collateral things , not finished ROT , wrong papers file etc.
Clinical efficacy with leronlimab was as no other drug approved,
81% efficacy with 350 mg of leronlimab , compare to 45% efficacy with Maraviroc , and 43% with ibalizumab , in the same category of patients..

And so many more other benefits HIV patients should have when using leronlimab , of course studies ongoing in some , or will be initiated in others , to prove all this , but look that leronlimab will also control.
--severe inflammation most HIV patients are diagnose with.
--HIV dementia many HIV patient are diagnosed with , leronlimab is crossing BBB..
--controlling to some point malignancies HIV patients are diagnosed with,
--liver problems , about 60-70% of HIV patients are diagnosed with ..

Leronlimab is a very unusual drug , and studies slowly are showing us this., and very unusual also is , that until now , in some patients close to 7 years of using , there were not one severe side effect to it..and no resistance to it in HIV.

--if CYDY is under DOJ and Sec investigation , this is VERY welcome. The sooner the better , and the more extensive the better..

--and money , yes it is , and was always not easy , but we did it until now , I don't expect problem from now on , not when we doing very well in combo in HIV , and we might be doing well in Covid , NASH , cancers and many more ,
only little more time is needed..

--and true , company is not making any money so far , but this is because of American law , I wanted to pay for my son treatment , but company told me it will be illegal for them to do it..I am sure many others will like to pay for a live saving drug , but for now law is as it is..

Lets just have the Brazilian study asap.

And good luck to leronlimab , then our patients will also be very lucky .
Finally a drug , really saving lives.

GLTA long..

All IMO.

[Upside08]

Speculation that the statement referenced has been photoshopped. If so all those referencing this photoshopped document will be implicated

[jimmy667]

This seems like a cut and paste from buyerstrike.com. A disreputable short seller like Citron and a possible RICO market manipulator. One must feel immune from the long arm of the Law to repeat such rubbish.